Current cancer drug targets
- Label
- Current cancer drug targets (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
- CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis. (Articolo in rivista) (Prodotto della ricerca)
- Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases (Articolo in rivista) (Prodotto della ricerca)
- Cytokines in the Management of High Risk or Advanced Breast Cancer: An Update and Expectation (Articolo in rivista) (Prodotto della ricerca)
- Biological agents involved in malignant mesothelioma: relevance as biomarkers or therapeutic targets (Articolo in rivista) (Prodotto della ricerca)
- Alternative label
- Current cancer drug targets. (literal)
- Language
- eng (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#issn
- 1568-0096 (literal)
- Preferred label
- Current cancer drug targets (literal)
- Publisher
- Bentham Science Publishers Hilversum : NLD (literal)
Incoming links:
- Rivista
- Biological agents involved in malignant mesothelioma: relevance as biomarkers or therapeutic targets (Articolo in rivista) (Prodotto della ricerca)
- Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases (Articolo in rivista) (Prodotto della ricerca)
- CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis. (Articolo in rivista) (Prodotto della ricerca)
- Cytokines in the Management of High Risk or Advanced Breast Cancer: An Update and Expectation (Articolo in rivista) (Prodotto della ricerca)
